• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of in vivo cytotoxicity assay system using humanized mice maintaining human mature NK cells for long-term

Research Project

Project/Area Number 16K18405
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Laboratory animal science
Research InstitutionCentral Institute for Experimental Animals

Principal Investigator

Katano Ikumi  公益財団法人実験動物中央研究所, 実験動物研究部, 研究員 (90442558)

Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywordsヒト化マウス / NK細胞 / ヒト免疫 / ADCC / NOGマウス / IL-15 / IL-2 / ヒトNK細胞
Outline of Final Research Achievements

We generated that a NOG-human IL-15 Tg mouse strain was useful for evaluating in vivo antibody-dependent cellular cytotoxicity (ADCC) mediated by human peripheral blood-derived NK cells in the presence of therapeutic antibody.
And, We generated immunoglobulin gamma Fc region receptor (FcRg)-deficient NOG-IL-15 Tg (NOG-FcRg KO IL-15 Tg) mice and investigated whether human NK cell-derived ADCC activity could be distinguished from mouse cell -mediated antibody-dependent cellular phagocytosis (ADCP). The Daudi-transplanted NOG-FcRg KO IL-15 Tg mice were intravenously transferred with in vitro expanded human NK cells and treated with rituximab. Only the group with human NK cells and rituximab treatment showed significant suppression of tumor growth in the kidney, while treatment with rituximab alone had minimum influence.
These data suggest that NOG-FcRg KO, IL-15 mice are more suitable for specifically detecting human NK cell mediated in vivo ADCC activity than NOG-IL-15 Tg mice.

Academic Significance and Societal Importance of the Research Achievements

がんに対する分子標的抗体の創薬研究において、抗体の機能解析は試験管内での検証系が主流である。しかし、この結果は生体での反応を必ずしも反映するものではなく、臨床研究で予期しない副作用が観察されることが多い。従って、ヒトの細胞に対する反応性を生体内で検証し得る動物モデルが求められてきた。従来のモデルでは抗体の細胞傷害機能-ADCC活性-の検証はほぼ不可能であったが、ヒトNK細胞を生着させたNOG-IL-15 Tgマウスで検証が可能となった。さらにNOG-FcRg KO, IL-15 TgマウスではADCC活性の検出感度を飛躍的に高めることができた。この動物モデルは創薬の発展に貢献するものと考える。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (8 results)

All 2019 2018 2017 2016

All Journal Article (4 results) (of which Int'l Joint Research: 4 results,  Peer Reviewed: 4 results,  Open Access: 2 results) Presentation (2 results) (of which Int'l Joint Research: 1 results) Patent(Industrial Property Rights) (2 results) (of which Overseas: 1 results)

  • [Journal Article] Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse2017

    • Author(s)
      Katano Ikumi、Nishime Chiyoko、Ito Ryoji、Kamisako Tsutomu、Mizusawa Takuma、Ka Yuyo、Ogura Tomoyuki、Suemizu Hiroshi、Kawakami Yutaka、Ito Mamoru、Takahashi Takeshi
    • Journal Title

      Sci Rep.

      Volume: 7 Issue: 1 Pages: 17230-17230

    • DOI

      10.1038/s41598-017-17442-7

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] A novel xenogeneic graft-versus-host disease model for investigating the pathological role of human CD4+ or CD8+ T cells using immunodeficient NOG mice.2017

    • Author(s)
      Ito R, Katano I, Kawai K, Yagoto M, Takahashi T, Ka Y, Ogura T, Takahashi R, Ito M
    • Journal Title

      American Journal of Transplantation

      Volume: 5 Issue: 5 Pages: 1216-1228

    • DOI

      10.1111/ajt.14116

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.2017

    • Author(s)
      Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Katano I, Ito M, Akiyama Y.
    • Journal Title

      Clinical Cancer Research

      Volume: 23(1) Issue: 1 Pages: 149-158

    • DOI

      10.1158/1078-0432.ccr-16-0122

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Generation of a Nonhuman Primate Model of Severe Combined Immunodeficiency Using Highly Efficient Genome Editing.2016

    • Author(s)
      Sato K, Oiwa R, Kumita W, Henry R, Sakuma T, Ito R, Nozu R, Inoue T, Katano I, Sato K, Okahara N, Okahara J, Shimizu Y, Yamamoto M, Hanazawa K, Kawakami T, Kametani Y, Suzuki R, Takahashi T, Weinstein EJ, Yamamoto T, Sakakibara Y, Habu S, Hata J, Okano H, Sasaki E.
    • Journal Title

      Cell Stem Cell

      Volume: 19 Issue: 1 Pages: 127-138

    • DOI

      10.1016/j.stem.2016.06.003

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] NOG-FcgR KO-hIL-15 Tg mice provide a highly sensitive assay system for ADCC activity of human NK cells2019

    • Author(s)
      Ikumi Katano, Iyo Ootsuka, Ryoji Ito, Kenji Kawai, Mika Yagoto, Hiroshi Suemizu, Mamoru Ito, Taichi Yamamoto, Takeshi Takahashi
    • Organizer
      AACR Annual Meeting 2019
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Specific detection of human NK cell mediated in vivo ADCC in FcgR-deficient NOG-human IL-15 transgenic mice2018

    • Author(s)
      Ikumi Katano, Asami Hanazawa, Ryoji Ito, Mamoru Ito, Takeshi Takahashi
    • Organizer
      第47回 日本免疫学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Patent(Industrial Property Rights)] 免疫不全マウス2018

    • Inventor(s)
      高橋武司、片野いくみ
    • Industrial Property Rights Holder
      高橋武司、片野いくみ
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2018-217229
    • Filing Date
      2018
    • Related Report
      2018 Annual Research Report
  • [Patent(Industrial Property Rights)] ヒトIL-15分泌免疫不全マウス2016

    • Inventor(s)
      伊藤守、片野いくみ
    • Industrial Property Rights Holder
      伊藤守、片野いくみ
    • Industrial Property Rights Type
      特許
    • Filing Date
      2016-04-20
    • Related Report
      2016 Research-status Report
    • Overseas

URL: 

Published: 2016-04-21   Modified: 2021-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi